Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Gowling WLG ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next
 
Title
Country
Organisation
Author
Date
1
Health Canada Responds To Medical Device Regulation Gaps
In late 2018, a series of news articles took aim at Canada's regulation of medical devices, alleging that Health Canada's medical device approval and adverse event monitoring systems were severely
Canada
24 May 2019
2
Khiron Life Sciences Forms Joint Venture With Dixie Brands To Bring Cannabis-Infused Products To Latin American Market
Khiron is a vertically integrated cannabis leader with core operations in Latin America.
Canada
1 Apr 2019
3
Benefits Of Industry Group Intervention In The Federal Court Of Canada
The Federal Court is tasked with hearing a wide variety of judicial review applications that can have a substantial impact on Canadian industry and technology sectors.
Canada
4 Mar 2019
4
Khiron Life Sciences Acquires Dayacann
On Jan. 21, 2019, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) announced that it had closed the previously announced MOU with Dayacann ...
Canada
24 Jan 2019
5
GSK Awarded Arrow Declaration In Patent Dispute With Vectura
GlaxoSmithKline ("GSK") has succeeded in the High Court of England and Wales in its patent dispute with Vectura, a UK based pharmaceutical company specialising in formulation of inhalable medicaments.
UK
18 Dec 2018
6
Health Canada Invites Public Comments On New Post-Market Reporting Regulations
An often-cited concern with the FDA's approval process relates to the 510(k) pathway, whereby a medical device may reach the market with a lesser amount of clinical testing.
Canada
16 Aug 2018
7
Drafting Leasing Agreements For Tenants In The Life Sciences Sector
When drafting leasing agreements with any business, it is important to consider how their needs may differ to the previous tenants or other occupants of the building.
Canada
26 Jul 2018
8
Life Sciences Disputes: Is International Arbitration The Future?
The growth of the life sciences sector has been accompanied by a corresponding growth in related disputes, which are increasingly resolved by way of international arbitration.
UK
13 Jun 2018
9
Parallel Import Guidance Clarified By CJEU
The Court of Justice of the European Union (CJEU) has issued a ruling clarifying what you can, and cannot, do if you wish to import goods from one Member State of the EU to another.
European Union
25 May 2018
10
The Skinny On Skinny Labels
In a recent decision of Federal Court (Bristol-Myers Squibb Canada v Apotex Inc., 2017 FC 1061), Justice Lafrenière dismissed the prohibition proceeding ...
Canada
27 Dec 2017
11
Revolutionising Africa's Healthcare System Through Innovation
Africa's healthcare is in the midst of an innovation revolution that, as PwC say, "…is transforming Africa's economic potential, creating new target markets and unprecedented consumer choice".
Worldwide
9 Oct 2017
12
Incentivising The Private Healthcare Sector In Africa
Africa is experiencing a period of strong economic growth, which in turn is accelerating the development and diversification of the health and care sector across the continent.
Worldwide
16 May 2017
13
Why Combatting Cyber-Crime Is Critical For Life Science Companies
Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks - so how are they protecting themselves?
Worldwide
3 May 2017
14
Evidence For Establishing Sound Prediction And The Use Of Trial And Error Experimentation To Establish An Enabling Disclosure
The Federal Court of Appeal's (FCA) recent decision in Teva v. Leo Pharma addresses important issues related to the doctrines of sound prediction and sufficiency.
Canada
13 Apr 2017
15
What Brexit Means For Life Sciences
This is borne out in our research, which reveals that companies in the life sciences sector are least likely to have changed their UK investment plans in the wake of Brexit.
Worldwide
16 Jan 2017
16
Federal Court Of Appeal Grants Minister Of Health The Right To Be Wrong
The Federal Court of Appeal upheld two decisions of the minister of health to issue "NOCs" to generic drug manufacturers without addressing the requirements of the Patented Medicines Regulations.
Canada
1 Nov 2016
17
Patent Survives Anticipation Attack Based On Use In Phase III Clinical Trial
On September 7, 2016, the Federal Court found that Apotex and Cobalt infringed three claims of Bayer's Canadian Letters Patent No. 2,382,426
Canada
26 Sep 2016
18
Court Of Appeal Confirms Genentech Herceptin Formulation Patents Invalid
The Court of Appeal has confirmed that two Genentech patents concerning lyophilised formulations of trastuzumab (the active ingredient in Herceptin) are invalid for obviousness.
Canada
2 Sep 2016
19
Portions Of Apotex's Requested Relief For Being Kept Off The Viagra® Market Struck
In a 2016 Ontario Superior Court of Justice decision Lederman J. ruled on a motion brought by the defendant Pfizer seeking to strike claims to multiple forms of relief sought by the plaintiff Apotex.
Canada
31 Aug 2016
20
Brexit - What Vote Leave Means For UK Life Sciences
On 23 June 2016, in a national referendum, the population of the UK voted by a narrow majority (52%) to leave the European Union (EU). What does this mean for the life sciences sector?
UK
8 Jul 2016
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next